Zosano Pharma Corp. (ZSAN) NASDAQ
$0.56 0.04 (7.23%)
Market Cap: -
As of 06/10/22 04:00 PM EDT. Market closed.
Zosano Pharma Corp. (ZSAN)
NASDAQ
$0.56
0.04 (7.23%)
Market Cap: -
As of 06/10/22 04:00 PM EDT. Market closed.
Add to Portfolio
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies. The company's transdermal microneedle system technology consists of titanium ... read more
COMPANY PROFILE
Sector
Industry
Sector
Industry
CEO
Steven Lo
Address
34790 Ardentech Ct, California, Fremont, 94555-3657.
PRICE CHART FOR ZOSANO PHARMA CORP
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.51
Previous Close
$0.52
Days Range
$0.46 - $0.64
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
4,902,260
Open
$0.51
Previous Close
$0.52
Days Range
$0.46 - $0.64
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
4,902,260
FINANCIAL STATEMENTS FOR ZOSANO PHARMA CORP
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ZOSANO PHARMA CORP
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Matthews Christine | Chief Financial Officer | Jun 06, 2022 | Sale | $0.71 | 82 | 58 | 4,183 | Jun 07, 2022, 07:39 PM |
| Lo Steven | Chief Executive Officer | Jun 06, 2022 | Sale | $0.71 | 442 | 314 | 13,163 | Jun 07, 2022, 07:37 PM |
| Matthews Christine | Chief Financial Officer | Mar 31, 2022 | Sale | $0.21 | 8,116 | 1,705 | 146,425 | Apr 01, 2022, 09:09 PM |
| KELLERMAN DONALD J | VP, Clinical Dev & Med Affairs | Mar 31, 2022 | Sale | $0.21 | 4,006 | 842 | 56,331 | Apr 01, 2022, 09:08 PM |
| Lo Steven | Chief Executive Officer | Mar 31, 2022 | Sale | $0.21 | 23,633 | 4,965 | 460,709 | Apr 01, 2022, 09:07 PM |
| GREATHOUSE KENNETH | Director | Nov 23, 2021 | Sale | $0.60 | 10,000 | 6,018 | 43,500 | Nov 24, 2021, 05:53 PM |
| Lo Steven | Chief Executive Officer | Jun 04, 2021 | Sale | $0.81 | 13,158 | 10,592 | 365,592 | Jun 07, 2021, 06:44 PM |
| KELLERMAN DONALD J | VP, Clinical Dev & Med Affairs | Jun 04, 2021 | Sale | $0.81 | 1,709 | 1,376 | 50,337 | Jun 07, 2021, 06:42 PM |
| GREATHOUSE KENNETH | Director | May 17, 2021 | Option Exercise | $0.73 | 21,000 | 15,311 | 38,500 | May 18, 2021, 07:45 PM |
| Aisling Capital IV, LP | 10% Owner | Dec 02, 2019 | Option Exercise | $1.45 | 689,655 | 1,000,000 | 2,718,226 | Dec 06, 2019, 10:23 AM |
| WALKER JOHN PETER | President & CEO | Apr 11, 2019 | Buy | $3.50 | 100,000 | 350,000 | 280,228 | Apr 18, 2019, 04:25 PM |
| Aisling Capital IV, LP | 10% Owner | Apr 11, 2019 | Option Exercise | $3.50 | 428,571 | 1,499,999 | 2,028,571 | Apr 12, 2019, 04:15 PM |
| Amzak Capital Management, LLC | 10% Owner | Feb 27, 2018 | Sale | $8.26 | 5,901 | 48,760 | 0 | Feb 28, 2018, 05:38 PM |
| Amzak Capital Management, LLC | 10% Owner | Feb 27, 2018 | Sale | $8.36 | 80,880 | 675,914 | 175,211 | Feb 28, 2018, 05:38 PM |
| Amzak Capital Management, LLC | 10% Owner | Feb 26, 2018 | Sale | $11.00 | 1,500 | 16,500 | 256,091 | Feb 28, 2018, 05:38 PM |
| GREATHOUSE KENNETH | Director | Dec 06, 2017 | Buy | $0.61 | 55,000 | 33,407 | 200,000 | Dec 08, 2017, 04:24 PM |
| GREATHOUSE KENNETH | Director | Dec 01, 2017 | Buy | $0.62 | 50,000 | 31,080 | 145,000 | Dec 04, 2017, 04:05 PM |
| GREATHOUSE KENNETH | Director | Nov 30, 2017 | Buy | $0.62 | 45,000 | 27,927 | 95,000 | Dec 04, 2017, 04:05 PM |
| GREATHOUSE KENNETH | Director | Nov 15, 2017 | Buy | $0.58 | 15,000 | 8,674 | 50,000 | Nov 16, 2017, 05:28 PM |
| GREATHOUSE KENNETH | Director | Nov 14, 2017 | Buy | $0.64 | 35,000 | 22,484 | 35,000 | Nov 16, 2017, 05:28 PM |
| WALKER JOHN PETER | Interim CEO | May 25, 2017 | Buy | $1.37 | 37,550 | 51,338 | 206,894 | May 26, 2017, 05:53 PM |
| WALKER JOHN PETER | Interim CEO | May 24, 2017 | Buy | $1.34 | 36,166 | 48,553 | 169,344 | May 26, 2017, 05:53 PM |
| Erbez Georgia | CFO and Chief Business Officer | May 25, 2017 | Buy | $1.32 | 68,000 | 89,760 | 115,750 | May 25, 2017, 08:55 PM |
| WALKER JOHN PETER | Interim CEO | May 25, 2017 | Buy | $1.37 | 37,550 | 51,338 | 206,894 | May 25, 2017, 08:45 PM |
| WALKER JOHN PETER | Interim CEO | May 24, 2017 | Buy | $1.34 | 36,166 | 48,553 | 169,344 | May 25, 2017, 08:45 PM |
| Alataris Konstantinos | President, CEO | Mar 20, 2017 | Option Exercise | $1.45 | 127,389 | 184,714 | 254,778 | Mar 22, 2017, 05:39 PM |
| BARRETT M JAMES | 10% Owner | Feb 13, 2017 | Sale | $2.01 | 1,099,996 | 2,211,432 | 952,809 | Feb 14, 2017, 05:37 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Feb 13, 2017 | Sale | $2.01 | 1,099,996 | 2,211,432 | 952,809 | Feb 14, 2017, 05:36 PM |
| BARRETT M JAMES | 10% Owner | Sep 16, 2016 | Sale | $0.75 | 7,471 | 5,603 | 2,052,805 | Sep 20, 2016, 04:39 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Sep 16, 2016 | Sale | $0.75 | 7,471 | 5,603 | 2,052,805 | Sep 20, 2016, 04:39 PM |
| BARRETT M JAMES | 10% Owner | Sep 13, 2016 | Sale | $0.74 | 10,000 | 7,400 | 2,060,276 | Sep 15, 2016, 04:31 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Sep 13, 2016 | Sale | $0.74 | 10,000 | 7,400 | 2,060,276 | Sep 15, 2016, 04:30 PM |
| BARRETT M JAMES | 10% Owner | Aug 29, 2016 | Sale | $1.01 | 50,000 | 50,440 | 2,070,276 | Aug 31, 2016, 04:36 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Aug 29, 2016 | Sale | $1.01 | 50,000 | 50,440 | 2,070,276 | Aug 31, 2016, 04:35 PM |
| BARRETT M JAMES | 10% Owner | Aug 24, 2016 | Sale | $1.21 | 1,200 | 1,452 | 2,120,276 | Aug 26, 2016, 05:08 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Aug 24, 2016 | Sale | $1.21 | 1,200 | 1,452 | 2,120,276 | Aug 26, 2016, 05:07 PM |
| Erbez Georgia | Interim CFO | Aug 19, 2016 | Buy | $1.32 | 47,750 | 63,030 | 47,750 | Aug 22, 2016, 07:46 PM |
| Lewis Hayley | VP, Reg Affairs & Quality | Aug 19, 2016 | Buy | $1.32 | 4,775 | 6,303 | 4,775 | Aug 22, 2016, 07:29 PM |
| KELLERMAN DONALD J | VP, Clinical Dev & Med Affairs | Aug 19, 2016 | Buy | $1.32 | 15,920 | 21,014 | 15,920 | Aug 22, 2016, 07:18 PM |
| WALKER JOHN PETER | Director | Aug 19, 2016 | Buy | $1.32 | 63,700 | 84,084 | 63,700 | Aug 22, 2016, 07:05 PM |
| Alataris Konstantinos | President, CEO | Aug 19, 2016 | Buy | $1.32 | 127,389 | 168,153 | 127,389 | Aug 22, 2016, 06:45 PM |
| XANTHOPOULOS KLEANTHIS G | Director | Aug 19, 2016 | Buy | $1.32 | 15,920 | 21,014 | 21,920 | Aug 22, 2016, 05:11 PM |
| BARRETT M JAMES | 10% Owner | Jul 21, 2016 | Sale | $1.33 | 8,989 | 11,957 | 2,121,476 | Jul 21, 2016, 04:32 PM |
| BARRETT M JAMES | 10% Owner | Jul 20, 2016 | Sale | $1.24 | 14,158 | 17,550 | 2,130,465 | Jul 21, 2016, 04:32 PM |
| BARRETT M JAMES | 10% Owner | Jul 19, 2016 | Sale | $1.17 | 534 | 625 | 2,144,623 | Jul 21, 2016, 04:32 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Jul 19, 2016 | Sale | $1.17 | 534 | 625 | 2,144,623 | Jul 21, 2016, 04:31 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Jul 21, 2016 | Sale | $1.33 | 8,989 | 11,957 | 2,121,476 | Jul 21, 2016, 04:31 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Jul 20, 2016 | Sale | $1.24 | 14,158 | 17,550 | 2,130,465 | Jul 21, 2016, 04:31 PM |
| BARRETT M JAMES | 10% Owner | Jul 13, 2016 | Sale | $1.20 | 13,382 | 16,060 | 2,145,157 | Jul 15, 2016, 04:34 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Jul 13, 2016 | Sale | $1.20 | 13,382 | 16,060 | 2,145,157 | Jul 15, 2016, 04:33 PM |
| BARRETT M JAMES | Director | Jan 30, 2015 | Option Exercise | $9.35 | 341,201 | 3,190,229 | 2,135,082 | Feb 02, 2015, 01:33 PM |
| BARRETT M JAMES | Director | Jan 30, 2015 | Buy | $11.00 | 23,457 | 258,027 | 2,158,539 | Feb 02, 2015, 01:33 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Jan 30, 2015 | Option Exercise | $9.35 | 341,201 | 3,190,229 | 2,135,082 | Feb 02, 2015, 01:32 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Jan 30, 2015 | Buy | $11.00 | 23,457 | 258,027 | 2,158,539 | Feb 02, 2015, 01:32 PM |
| BioMed Realty Trust Inc | 10% Owner | Jan 30, 2015 | Option Exercise | $9.35 | 317,409 | 2,967,774 | 1,896,982 | Feb 02, 2015, 01:17 PM |
| BioMed Realty Trust Inc | 10% Owner | Jan 30, 2015 | Option Exercise | $9.35 | 64,661 | 604,580 | 518,904 | Feb 02, 2015, 01:17 PM |
| BioMed Realty Trust Inc | 10% Owner | Jan 30, 2015 | Buy | $11.00 | 26,543 | 291,973 | 545,447 | Feb 02, 2015, 01:17 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR ZOSANO PHARMA CORP
LOADING...